[
  {
    "ticker": "MRK",
    "name": "Merck & Co.",
    "marketCap": 225739948032,
    "revenueGrowth": 0.037,
    "debtToEquity": 79.708,
    "trailingPE": 12.030423,
    "momentum_2m": 0.0905771048480144,
    "momentum_1w": 0.08454562707235946,
    "FundamentalFilterRating": 83,
    "price": 90.94999694824219,
    "RSI (14)": 60.97,
    "EMA (20)": 86.28,
    "MACD (12,26,9)": 0.3747,
    "MACD_Signal (12,26,9)": 0.0468,
    "percent_change": 4.84,
    "TechFilterRating": 100.0,
    "news_sentiment_percent": 75.0,
    "social_sentiment_percent": null,
    "sector": "Healthcare",
    "sector_name": "XLV",
    "market_change_1d": -0.8256436690967983,
    "market_change_5d": -3.3489572743467533,
    "market_change_20d": -1.7523999751486108,
    "market_trend": "down",
    "sector_change_1d": 0.586683854682013,
    "sector_change_5d": 1.2675894312121017,
    "sector_change_20d": 5.140213053187592,
    "sector_trend": "up",
    "OverallRating": 94.6,
    "AITicker": "Merck & Co., známa farmaceutická spoločnosť, sa zameriava na vývoj liekov a vakcín.",
    "AIComment": "Merck & Co. vykazuje silný týždenný moment a pozitívny sentiment správ, čo naznačuje potenciál pre krátkodobý rast. Napriek nedávnemu poklesu trhu, sektor zdravotnej starostlivosti, v ktorom firma pôsobí, zaznamenal rast, čo by mohlo podporiť akcie MRK. Vzhľadom na technické ukazovatele ako RSI a MACD, ktoré sú v pozitívnych oblastiach, sa zdá, že MRK má dobrý potenciál pre obchodovanie v krátkodobom horizonte 2-10 dní.",
    "AIScore": 78,
    "SL": 88.22,
    "TP": 94.59,
    "SL10": 9.7,
    "TP10": 10.4
  },
  {
    "ticker": "MTD",
    "name": "Mettler Toledo",
    "marketCap": 29520328704,
    "revenueGrowth": 0.079,
    "debtToEquity": null,
    "trailingPE": 36.099426,
    "momentum_2m": 0.10198892549691019,
    "momentum_1w": 0.017397179168900934,
    "FundamentalFilterRating": 66,
    "price": 1445.06005859375,
    "RSI (14)": 64.58,
    "EMA (20)": 1399.56,
    "MACD (12,26,9)": 32.7244,
    "MACD_Signal (12,26,9)": 31.747,
    "percent_change": 0.87,
    "TechFilterRating": 100.0,
    "news_sentiment_percent": 75.0,
    "social_sentiment_percent": null,
    "sector": "Healthcare",
    "sector_name": "XLV",
    "market_change_1d": -0.8256436690967983,
    "market_change_5d": -3.3489572743467533,
    "market_change_20d": -1.7523999751486108,
    "market_trend": "down",
    "sector_change_1d": 0.586683854682013,
    "sector_change_5d": 1.2675894312121017,
    "sector_change_20d": 5.140213053187592,
    "sector_trend": "up",
    "OverallRating": 88.4,
    "AITicker": "Mettler Toledo is a global provider of precision instruments and services for professional use in the healthcare sector.",
    "AIComment": "Mettler Toledo shows a positive short-term trading outlook, supported by its recent momentum and technical indicators like a rising MACD above its signal line and an RSI below the overbought threshold. Despite a downward trend in the broader market, the healthcare sector, to which MTD belongs, is trending upwards, which could buffer negative market influences.",
    "AIScore": 78,
    "SL": 1401.71,
    "TP": 1517.31,
    "SL10": 9.7,
    "TP10": 10.5
  },
  {
    "ticker": "STE",
    "name": "Steris",
    "marketCap": 26175807488,
    "revenueGrowth": 0.099,
    "debtToEquity": 29.314,
    "trailingPE": 38.15451,
    "momentum_2m": 0.09337095162787512,
    "momentum_1w": 0.10274966084921,
    "FundamentalFilterRating": 66,
    "price": 266.70001220703125,
    "RSI (14)": 81.56,
    "EMA (20)": 247.22,
    "MACD (12,26,9)": 6.1832,
    "MACD_Signal (12,26,9)": 3.184,
    "percent_change": 1.02,
    "TechFilterRating": 75.0,
    "news_sentiment_percent": 83.3,
    "social_sentiment_percent": null,
    "sector": "Healthcare",
    "sector_name": "XLV",
    "market_change_1d": -0.8256436690967983,
    "market_change_5d": -3.3489572743467533,
    "market_change_20d": -1.7523999751486108,
    "market_trend": "down",
    "sector_change_1d": 0.586683854682013,
    "sector_change_5d": 1.2675894312121017,
    "sector_change_20d": 5.140213053187592,
    "sector_trend": "up",
    "OverallRating": 82.2,
    "AITicker": "Steris, a company in the Healthcare sector, specializes in infection prevention, decontamination, and surgical and critical care.",
    "AIComment": "Steris shows strong short-term potential given its recent performance and sector trends. The stock has outperformed with a positive momentum and a high RSI, indicating strong buying interest. However, caution is advised due to its high RSI, which might suggest overbought conditions. The positive sector trend supports potential gains, contrasting the general market downturn.",
    "AIScore": 78,
    "SL": 258.7,
    "TP": 274.7,
    "SL10": 9.7,
    "TP10": 10.3
  },
  {
    "ticker": "MNST",
    "name": "Monster Beverage",
    "marketCap": 70257598464,
    "revenueGrowth": 0.168,
    "debtToEquity": 0.779,
    "trailingPE": 40.857956,
    "momentum_2m": 0.12149096353466082,
    "momentum_1w": 0.07537013172599205,
    "FundamentalFilterRating": 83,
    "price": 71.91000366210938,
    "RSI (14)": 58.68,
    "EMA (20)": 68.52,
    "MACD (12,26,9)": 0.4042,
    "MACD_Signal (12,26,9)": 0.1224,
    "percent_change": 2.68,
    "TechFilterRating": 100.0,
    "news_sentiment_percent": 83.3,
    "social_sentiment_percent": null,
    "sector": "Consumer Defensive",
    "sector_name": "XLP",
    "market_change_1d": -0.8256436690967983,
    "market_change_5d": -3.3489572743467533,
    "market_change_20d": -1.7523999751486108,
    "market_trend": "down",
    "sector_change_1d": 0.4298578161843647,
    "sector_change_5d": -0.4261937617900613,
    "sector_change_20d": -2.762015911362392,
    "sector_trend": "neutral",
    "OverallRating": 79.9,
    "AITicker": "Monster Beverage je výrobca a distribútor energetických nápojov a alternatívnych nápojov, známy predovšetkým svojou značkou Monster Energy.",
    "AIComment": "Napriek poklesu trhu v posledných 5 dňoch, Monster Beverage ukazuje silný rast cien a pozitívny sentiment správ. S RSI blízko 60 a pozitívnym MACD nad signálom, akcia vykazuje silu v krátkodobom horizonte. Vzhľadom na neutrálny trend v sektore a rastúci moment v posledných týždňoch, MNST by mohla byť dobrá krátkodobá investícia.",
    "AIScore": 78,
    "SL": 69.75,
    "TP": 75.51,
    "SL10": 9.7,
    "TP10": 10.5
  },
  {
    "ticker": "BMY",
    "name": "Bristol Myers Squibb",
    "marketCap": 99181895680,
    "revenueGrowth": 0.028,
    "debtToEquity": 274.414,
    "trailingPE": 16.404041,
    "momentum_2m": 0.024893579765943752,
    "momentum_1w": 0.06865543008640596,
    "FundamentalFilterRating": 66,
    "price": 48.720001220703125,
    "RSI (14)": 74.41,
    "EMA (20)": 45.46,
    "MACD (12,26,9)": 1.0165,
    "MACD_Signal (12,26,9)": 0.6169,
    "percent_change": 3.09,
    "TechFilterRating": 75.0,
    "news_sentiment_percent": 75.0,
    "social_sentiment_percent": null,
    "sector": "Healthcare",
    "sector_name": "XLV",
    "market_change_1d": -0.8256436690967983,
    "market_change_5d": -3.3489572743467533,
    "market_change_20d": -1.7523999751486108,
    "market_trend": "down",
    "sector_change_1d": 0.586683854682013,
    "sector_change_5d": 1.2675894312121017,
    "sector_change_20d": 5.140213053187592,
    "sector_trend": "up",
    "OverallRating": 79.2,
    "AITicker": "Bristol Myers Squibb je globálna biopharmaceutická spoločnosť zameraná na vývoj liekov v oblasti onkológie, kardiovaskulárnych a imunologických porúch.",
    "AIComment": "Bristol Myers Squibb (BMY) vykazuje silný krátkodobý rastový potenciál, podporený pozitívnym sentimentom v sektore zdravotnej starostlivosti a nedávnym zvýšením ceny akcií. Avšak vysoký RSI (74.41) naznačuje možnú prekúpenosť, čo by mohlo viesť k krátkodobej korekcii. Vzhľadom na pozitívny MACD a sektorový trend by mohla byť akcia stále atraktívnou voľbou pre krátkodobé obchodovanie.",
    "AIScore": 78,
    "SL": 47.26,
    "TP": 50.18,
    "SL10": 9.7,
    "TP10": 10.3
  },
  {
    "ticker": "INCY",
    "name": "Incyte",
    "marketCap": 21234264064,
    "revenueGrowth": 0.2,
    "debtToEquity": 0.887,
    "trailingPE": 18.332203,
    "momentum_2m": 0.2736694064327334,
    "momentum_1w": 0.05091338502127152,
    "FundamentalFilterRating": 100,
    "price": 108.16000366210938,
    "RSI (14)": 87.36,
    "EMA (20)": 97.25,
    "MACD (12,26,9)": 5.488,
    "MACD_Signal (12,26,9)": 4.0238,
    "percent_change": 2.06,
    "TechFilterRating": 75.0,
    "news_sentiment_percent": 83.3,
    "social_sentiment_percent": null,
    "sector": "Healthcare",
    "sector_name": "XLV",
    "market_change_1d": -0.8256436690967983,
    "market_change_5d": -3.3489572743467533,
    "market_change_20d": -1.7523999751486108,
    "market_trend": "down",
    "sector_change_1d": 0.586683854682013,
    "sector_change_5d": 1.2675894312121017,
    "sector_change_20d": 5.140213053187592,
    "sector_trend": "up",
    "OverallRating": 94.7,
    "AITicker": "Incyte is a biopharmaceutical company focused on the discovery, development, and commercialization of proprietary therapeutics.",
    "AIComment": "Incyte's stock shows strong short-term momentum with a significant rise in price and positive technical indicators such as a high RSI and a MACD above its signal line. Despite the overall market trending down, the healthcare sector, to which Incyte belongs, is trending up, which could support further gains. However, the extremely high RSI suggests the stock might be overbought, which could lead to a pullback.",
    "AIScore": 75,
    "SL": 104.92,
    "TP": 112.49,
    "SL10": 9.7,
    "TP10": 10.4
  },
  {
    "ticker": "BIIB",
    "name": "Biogen",
    "marketCap": 23407814656,
    "revenueGrowth": 0.028,
    "debtToEquity": 36.194,
    "trailingPE": 14.531877,
    "momentum_2m": 0.17401216436783762,
    "momentum_1w": 0.0685059639864789,
    "FundamentalFilterRating": 66,
    "price": 159.55999755859375,
    "RSI (14)": 69.93,
    "EMA (20)": 151.45,
    "MACD (12,26,9)": 3.0273,
    "MACD_Signal (12,26,9)": 2.1415,
    "percent_change": 2.11,
    "TechFilterRating": 100.0,
    "news_sentiment_percent": 83.3,
    "social_sentiment_percent": null,
    "sector": "Healthcare",
    "sector_name": "XLV",
    "market_change_1d": -0.8256436690967983,
    "market_change_5d": -3.3489572743467533,
    "market_change_20d": -1.7523999751486108,
    "market_trend": "down",
    "sector_change_1d": 0.586683854682013,
    "sector_change_5d": 1.2675894312121017,
    "sector_change_20d": 5.140213053187592,
    "sector_trend": "up",
    "OverallRating": 91.4,
    "AITicker": "Biogen is a biotechnology company specializing in therapies for neurological and neurodegenerative diseases.",
    "AIComment": "Biogen shows potential for a short-term trade given its positive momentum and strong technical indicators such as a high RSI and positive MACD above its signal. The healthcare sector is trending up, which supports potential gains. However, the overall market downtrend could pose risks, suggesting a cautious approach.",
    "AIScore": 75,
    "SL": 154.77,
    "TP": 167.54,
    "SL10": 9.7,
    "TP10": 10.5
  },
  {
    "ticker": "MDT",
    "name": "Medtronic",
    "marketCap": 122361577472,
    "revenueGrowth": 0.084,
    "debtToEquity": 59.437,
    "trailingPE": 26.353592,
    "momentum_2m": 0.03570444692302832,
    "momentum_1w": 0.055076348792096885,
    "FundamentalFilterRating": 83,
    "price": 95.4000015258789,
    "RSI (14)": 48.01,
    "EMA (20)": 92.98,
    "MACD (12,26,9)": -0.7787,
    "MACD_Signal (12,26,9)": -1.0104,
    "percent_change": 2.96,
    "TechFilterRating": 100.0,
    "news_sentiment_percent": 91.7,
    "social_sentiment_percent": null,
    "sector": "Healthcare",
    "sector_name": "XLV",
    "market_change_1d": -0.8256436690967983,
    "market_change_5d": -3.3489572743467533,
    "market_change_20d": -1.7523999751486108,
    "market_trend": "down",
    "sector_change_1d": 0.586683854682013,
    "sector_change_5d": 1.2675894312121017,
    "sector_change_20d": 5.140213053187592,
    "sector_trend": "up",
    "OverallRating": 100,
    "AITicker": "Medtronic is a global healthcare technology company specializing in medical devices and therapies.",
    "AIComment": "Medtronic (MDT) shows potential for a short-term trade, given its recent price increase of 2.96% and positive momentum indicators. The healthcare sector is trending upwards, which could support further gains. However, the overall market trend is down, which might limit the upside potential.",
    "AIScore": 72,
    "SL": 92.54,
    "TP": 99.22,
    "SL10": 9.7,
    "TP10": 10.4
  },
  {
    "ticker": "UHS",
    "name": "Universal Health Services",
    "marketCap": 14021695488,
    "revenueGrowth": 0.134,
    "debtToEquity": 70.037,
    "trailingPE": 10.686191,
    "momentum_2m": 0.2648919397115066,
    "momentum_1w": 0.0009813159298244223,
    "FundamentalFilterRating": 83,
    "price": 224.41000366210938,
    "RSI (14)": 63.89,
    "EMA (20)": 217.43,
    "MACD (12,26,9)": 6.4503,
    "MACD_Signal (12,26,9)": 5.9942,
    "percent_change": 0.8,
    "TechFilterRating": 100.0,
    "news_sentiment_percent": 75.0,
    "social_sentiment_percent": null,
    "sector": "Healthcare",
    "sector_name": "XLV",
    "market_change_1d": -0.8256436690967983,
    "market_change_5d": -3.3489572743467533,
    "market_change_20d": -1.7523999751486108,
    "market_trend": "down",
    "sector_change_1d": 0.586683854682013,
    "sector_change_5d": 1.2675894312121017,
    "sector_change_20d": 5.140213053187592,
    "sector_trend": "up",
    "OverallRating": 94.6,
    "AITicker": "Universal Health Services (UHS) is a company in the healthcare sector, providing hospital and healthcare services.",
    "AIComment": "Despite the general market showing a downward trend over the past 5 days, the healthcare sector, to which UHS belongs, has shown resilience with an upward trend. UHS itself has shown a slight positive momentum over the past week and has a strong news sentiment. Given the positive sector performance and UHS's stable technical indicators, the stock might be a reasonable short-term trade.",
    "AIScore": 72,
    "SL": 217.68,
    "TP": 235.63,
    "SL10": 9.7,
    "TP10": 10.5
  },
  {
    "ticker": "REGN",
    "name": "Regeneron Pharmaceuticals",
    "marketCap": 70894845952,
    "revenueGrowth": 0.009,
    "debtToEquity": 8.739,
    "trailingPE": 16.18014,
    "momentum_2m": 0.17535853941867763,
    "momentum_1w": 0.07412418438370816,
    "FundamentalFilterRating": 66,
    "price": 674.5499877929688,
    "RSI (14)": 76.62,
    "EMA (20)": 625.27,
    "MACD (12,26,9)": 24.7996,
    "MACD_Signal (12,26,9)": 21.0924,
    "percent_change": 3.03,
    "TechFilterRating": 75.0,
    "news_sentiment_percent": 75.0,
    "social_sentiment_percent": null,
    "sector": "Healthcare",
    "sector_name": "XLV",
    "market_change_1d": -0.8256436690967983,
    "market_change_5d": -3.3489572743467533,
    "market_change_20d": -1.7523999751486108,
    "market_trend": "down",
    "sector_change_1d": 0.586683854682013,
    "sector_change_5d": 1.2675894312121017,
    "sector_change_20d": 5.140213053187592,
    "sector_trend": "up",
    "OverallRating": 79.2,
    "AITicker": "Regeneron Pharmaceuticals, a healthcare company, specializes in the development of pharmaceutical products for the treatment of serious medical conditions.",
    "AIComment": "Regeneron Pharmaceuticals shows strong short-term momentum with a recent price increase and positive technical indicators such as a high RSI and MACD above its signal. However, the high RSI could also indicate overbought conditions, suggesting potential for a pullback. The overall market is trending down while the healthcare sector is trending up, which could provide some support for REGN.",
    "AIScore": 72,
    "SL": 654.31,
    "TP": 701.53,
    "SL10": 9.7,
    "TP10": 10.4
  },
  {
    "ticker": "FANG",
    "name": "Diamondback Energy",
    "marketCap": 42448764928,
    "revenueGrowth": 0.42,
    "debtToEquity": 35.66,
    "trailingPE": 10.403791,
    "momentum_2m": 0.06185485492940779,
    "momentum_1w": 0.06261652447420274,
    "FundamentalFilterRating": 83,
    "price": 148.14999389648438,
    "RSI (14)": 58.98,
    "EMA (20)": 142.69,
    "MACD (12,26,9)": 0.4884,
    "MACD_Signal (12,26,9)": 0.0377,
    "percent_change": 2.36,
    "TechFilterRating": 100.0,
    "news_sentiment_percent": 75.0,
    "social_sentiment_percent": null,
    "sector": "Energy",
    "sector_name": "XLE",
    "market_change_1d": -0.8256436690967983,
    "market_change_5d": -3.3489572743467533,
    "market_change_20d": -1.7523999751486108,
    "market_trend": "down",
    "sector_change_1d": 0.7969905356318252,
    "sector_change_5d": -0.5134941843891183,
    "sector_change_20d": 5.040944738859809,
    "sector_trend": "neutral",
    "OverallRating": 77.4,
    "AITicker": "Diamondback Energy, Inc. (FANG) is an energy company focused on the exploration, development, and production of oil and natural gas reserves in the United States.",
    "AIComment": "Despite a recent downturn in the broader market, Diamondback Energy shows strong individual performance with a positive momentum and a high news sentiment. The neutral sector trend and the company's solid financial metrics, including a reasonable debt-to-equity ratio and a low trailing PE, suggest resilience. However, caution is advised due to the overall negative market trend.",
    "AIScore": 72,
    "SL": 143.71,
    "TP": 154.08,
    "SL10": 9.7,
    "TP10": 10.4
  },
  {
    "ticker": "VRTX",
    "name": "Vertex Pharmaceuticals",
    "marketCap": 108901195776,
    "revenueGrowth": 0.11,
    "debtToEquity": 10.594,
    "trailingPE": 30.205488,
    "momentum_2m": 0.10090283124346211,
    "momentum_1w": 0.01790496727902302,
    "FundamentalFilterRating": 83,
    "price": 429.2200012207031,
    "RSI (14)": 52.37,
    "EMA (20)": 418.68,
    "MACD (12,26,9)": 2.5604,
    "MACD_Signal (12,26,9)": 2.741,
    "percent_change": 1.9,
    "TechFilterRating": 75.0,
    "news_sentiment_percent": 75.0,
    "social_sentiment_percent": null,
    "sector": "Healthcare",
    "sector_name": "XLV",
    "market_change_1d": -0.8256436690967983,
    "market_change_5d": -3.3489572743467533,
    "market_change_20d": -1.7523999751486108,
    "market_trend": "down",
    "sector_change_1d": 0.586683854682013,
    "sector_change_5d": 1.2675894312121017,
    "sector_change_20d": 5.140213053187592,
    "sector_trend": "up",
    "OverallRating": 85.4,
    "AITicker": "Vertex Pharmaceuticals is a biotechnology company focusing on developing and commercializing therapies for the treatment of cystic fibrosis and other severe diseases.",
    "AIComment": "Despite the general market downturn over the past 5 days, Vertex Pharmaceuticals shows resilience with a positive sector trend and a slight increase in momentum. The company's strong news sentiment and stable financial metrics suggest potential for short-term trading. However, caution is advised due to the overall negative market trend.",
    "AIScore": 68,
    "SL": 416.34,
    "TP": 450.68,
    "SL10": 9.7,
    "TP10": 10.5
  },
  {
    "ticker": "WAT",
    "name": "Waters Corporation",
    "marketCap": 22988744704,
    "revenueGrowth": 0.08,
    "debtToEquity": 66.042,
    "trailingPE": 35.458218,
    "momentum_2m": 0.33427789492820836,
    "momentum_1w": 0.05117879484392995,
    "FundamentalFilterRating": 66,
    "price": 386.1400146484375,
    "RSI (14)": 73.33,
    "EMA (20)": 358.02,
    "MACD (12,26,9)": 10.024,
    "MACD_Signal (12,26,9)": 6.628,
    "percent_change": 2.54,
    "TechFilterRating": 75.0,
    "news_sentiment_percent": 75.0,
    "social_sentiment_percent": null,
    "sector": "Healthcare",
    "sector_name": "XLV",
    "market_change_1d": -0.8256436690967983,
    "market_change_5d": -3.3489572743467533,
    "market_change_20d": -1.7523999751486108,
    "market_trend": "down",
    "sector_change_1d": 0.586683854682013,
    "sector_change_5d": 1.2675894312121017,
    "sector_change_20d": 5.140213053187592,
    "sector_trend": "up",
    "OverallRating": 79.2,
    "AITicker": "Waters Corporation is a company in the healthcare sector, specializing in analytical laboratory instrument manufacturing.",
    "AIComment": "Waters Corporation shows a strong short-term buying signal with a high RSI and positive momentum, indicating recent investor enthusiasm. However, the high RSI also suggests potential overbought conditions, which could lead to a pullback. The positive sector trend supports potential gains, but the overall market downtrend could temper short-term performance.",
    "AIScore": 68,
    "SL": 374.56,
    "TP": 405.45,
    "SL10": 9.7,
    "TP10": 10.5
  },
  {
    "ticker": "ABT",
    "name": "Abbott Laboratories",
    "marketCap": 220836741120,
    "revenueGrowth": 0.069,
    "debtToEquity": 25.31,
    "trailingPE": 15.954774,
    "momentum_2m": -0.0207665579671652,
    "momentum_1w": 0.00953892622521213,
    "FundamentalFilterRating": 66,
    "price": 127.0,
    "RSI (14)": 46.44,
    "EMA (20)": 126.62,
    "MACD (12,26,9)": -1.0734,
    "MACD_Signal (12,26,9)": -1.2908,
    "percent_change": 0.88,
    "TechFilterRating": 100.0,
    "news_sentiment_percent": 91.7,
    "social_sentiment_percent": null,
    "sector": "Healthcare",
    "sector_name": "XLV",
    "market_change_1d": -0.8256436690967983,
    "market_change_5d": -3.3489572743467533,
    "market_change_20d": -1.7523999751486108,
    "market_trend": "down",
    "sector_change_1d": 0.586683854682013,
    "sector_change_5d": 1.2675894312121017,
    "sector_change_20d": 5.140213053187592,
    "sector_trend": "up",
    "OverallRating": 94.5,
    "AITicker": "Abbott Laboratories is a global healthcare company specializing in diagnostics, medical devices, nutritionals, and branded generic medicines.",
    "AIComment": "Abbott Laboratories shows a mixed short-term trading outlook. While the overall market trend is downward, the healthcare sector, to which ABT belongs, is showing resilience with an upward trend. The company's recent positive momentum and strong news sentiment suggest potential for short-term gains, despite a slightly bearish MACD and an RSI indicating neither overbought nor oversold conditions.",
    "AIScore": 65,
    "SL": 124.09,
    "TP": 132.08,
    "SL10": 9.77,
    "TP10": 10.4
  },
  {
    "ticker": "AMGN",
    "name": "Amgen",
    "marketCap": 182248783872,
    "revenueGrowth": 0.124,
    "debtToEquity": 567.491,
    "trailingPE": 26.175562,
    "momentum_2m": 0.1660024820710111,
    "momentum_1w": 0.1407145206683298,
    "FundamentalFilterRating": 83,
    "price": 338.45001220703125,
    "RSI (14)": 82.4,
    "EMA (20)": 306.41,
    "MACD (12,26,9)": 8.0851,
    "MACD_Signal (12,26,9)": 3.9267,
    "percent_change": 4.57,
    "TechFilterRating": 75.0,
    "news_sentiment_percent": 83.3,
    "social_sentiment_percent": null,
    "sector": "Healthcare",
    "sector_name": "XLV",
    "market_change_1d": -0.8256436690967983,
    "market_change_5d": -3.3489572743467533,
    "market_change_20d": -1.7523999751486108,
    "market_trend": "down",
    "sector_change_1d": 0.586683854682013,
    "sector_change_5d": 1.2675894312121017,
    "sector_change_20d": 5.140213053187592,
    "sector_trend": "up",
    "OverallRating": 88.5,
    "AITicker": "Amgen is a biotechnology firm focused on developing innovative therapeutics in areas such as oncology, nephrology, and cardiology.",
    "AIComment": "Amgen shows strong short-term momentum with a significant rise in price and positive technical indicators like a high RSI and MACD above its signal. However, the high RSI suggests the stock might be overbought, posing a risk for a potential pullback. The positive sector trend supports growth, but the overall market downtrend could limit upside potential.",
    "AIScore": 65,
    "SL": 328.3,
    "TP": 351.99,
    "SL10": 9.7,
    "TP10": 10.4
  },
  {
    "ticker": "LH",
    "name": "Labcorp",
    "marketCap": 22234607616,
    "revenueGrowth": 0.086,
    "debtToEquity": 75.557,
    "trailingPE": 26.320904,
    "momentum_2m": -0.0058663658111521855,
    "momentum_1w": 0.06293341857404555,
    "FundamentalFilterRating": 66,
    "price": 268.2099914550781,
    "RSI (14)": 40.8,
    "EMA (20)": 263.89,
    "MACD (12,26,9)": -5.6007,
    "MACD_Signal (12,26,9)": -5.589,
    "percent_change": 2.71,
    "TechFilterRating": 75.0,
    "news_sentiment_percent": 83.3,
    "social_sentiment_percent": null,
    "sector": "Healthcare",
    "sector_name": "XLV",
    "market_change_1d": -0.8256436690967983,
    "market_change_5d": -3.3489572743467533,
    "market_change_20d": -1.7523999751486108,
    "market_trend": "down",
    "sector_change_1d": 0.586683854682013,
    "sector_change_5d": 1.2675894312121017,
    "sector_change_20d": 5.140213053187592,
    "sector_trend": "up",
    "OverallRating": 82.2,
    "AITicker": "Labcorp (LH) is a healthcare company specializing in diagnostics and drug development services.",
    "AIComment": "Labcorp shows a positive short-term momentum and a strong news sentiment, which could support its stock price in the next 2-10 days. However, the overall market trend is downward, which might limit the upside potential. The healthcare sector is performing well, which could provide some buffer against the negative market trend.",
    "AIScore": 65,
    "SL": 260.16,
    "TP": 278.94,
    "SL10": 9.7,
    "TP10": 10.4
  },
  {
    "ticker": "CMS",
    "name": "CMS Energy",
    "marketCap": 22775291904,
    "revenueGrowth": 0.16,
    "debtToEquity": 191.634,
    "trailingPE": 21.567722,
    "momentum_2m": 0.04686839499313722,
    "momentum_1w": 0.03380758464859035,
    "FundamentalFilterRating": 83,
    "price": 74.83999633789062,
    "RSI (14)": 51.27,
    "EMA (20)": 73.24,
    "MACD (12,26,9)": 0.0172,
    "MACD_Signal (12,26,9)": -0.1068,
    "percent_change": 1.05,
    "TechFilterRating": 100.0,
    "news_sentiment_percent": 83.3,
    "social_sentiment_percent": null,
    "sector": "Utilities",
    "sector_name": "XLU",
    "market_change_1d": -0.8256436690967983,
    "market_change_5d": -3.3489572743467533,
    "market_change_20d": -1.7523999751486108,
    "market_trend": "down",
    "sector_change_1d": -0.37962968642131223,
    "sector_change_5d": -0.5462020608295148,
    "sector_change_20d": -1.5340463307420338,
    "sector_trend": "neutral",
    "OverallRating": 79.9,
    "AITicker": "CMS Energy is an energy company primarily focused on providing electricity and natural gas to customers in Michigan, USA.",
    "AIComment": "CMS Energy shows a positive momentum and a favorable technical setup with its price above the EMA(20) and a bullish MACD crossover. However, the overall market trend is downward and the utilities sector is neutral, which might limit the upside potential. Given the mixed signals from market and sector trends, caution is advised for short-term trading.",
    "AIScore": 65,
    "SL": 72.59,
    "TP": 77.83,
    "SL10": 9.7,
    "TP10": 10.4
  },
  {
    "ticker": "ATO",
    "name": "Atmos Energy",
    "marketCap": 28679141376,
    "revenueGrowth": 0.196,
    "debtToEquity": 67.241,
    "trailingPE": 24.676796,
    "momentum_2m": 0.09492043806685091,
    "momentum_1w": 0.027076785263000724,
    "FundamentalFilterRating": 83,
    "price": 178.66000366210938,
    "RSI (14)": 53.98,
    "EMA (20)": 175.5,
    "MACD (12,26,9)": 0.1723,
    "MACD_Signal (12,26,9)": -0.2884,
    "percent_change": 0.51,
    "TechFilterRating": 100.0,
    "news_sentiment_percent": 75.0,
    "social_sentiment_percent": null,
    "sector": "Utilities",
    "sector_name": "XLU",
    "market_change_1d": -0.8256436690967983,
    "market_change_5d": -3.3489572743467533,
    "market_change_20d": -1.7523999751486108,
    "market_trend": "down",
    "sector_change_1d": -0.37962968642131223,
    "sector_change_5d": -0.5462020608295148,
    "sector_change_20d": -1.5340463307420338,
    "sector_trend": "neutral",
    "OverallRating": 77.4,
    "AITicker": "Atmos Energy, a utility company, primarily engages in the distribution and storage of natural gas.",
    "AIComment": "Despite a recent downturn in the broader market, Atmos Energy shows resilience with a positive momentum and a strong news sentiment. The stock's technical indicators like a rising MACD above its signal and a stable RSI suggest a potential for short-term gains. However, the neutral sector trend and negative market trend could limit upside potential.",
    "AIScore": 65,
    "SL": 173.3,
    "TP": 185.81,
    "SL10": 9.7,
    "TP10": 10.4
  },
  {
    "ticker": "KO",
    "name": "Coca-Cola Company (The)",
    "marketCap": 308038205440,
    "revenueGrowth": 0.051,
    "debtToEquity": 144.771,
    "trailingPE": 23.711922,
    "momentum_2m": 0.043818726016303655,
    "momentum_1w": 0.042965289701406784,
    "FundamentalFilterRating": 83,
    "price": 71.61000061035156,
    "RSI (14)": 54.44,
    "EMA (20)": 69.22,
    "MACD (12,26,9)": 0.7131,
    "MACD_Signal (12,26,9)": 0.5656,
    "percent_change": 1.55,
    "TechFilterRating": 100.0,
    "news_sentiment_percent": 75.0,
    "social_sentiment_percent": null,
    "sector": "Consumer Defensive",
    "sector_name": "XLP",
    "market_change_1d": -0.8256436690967983,
    "market_change_5d": -3.3489572743467533,
    "market_change_20d": -1.7523999751486108,
    "market_trend": "down",
    "sector_change_1d": 0.4298578161843647,
    "sector_change_5d": -0.4261937617900613,
    "sector_change_20d": -2.762015911362392,
    "sector_trend": "neutral",
    "OverallRating": 77.4,
    "AITicker": "Coca-Cola Company (KO) je globálny výrobca nealkoholických nápojov a rôznych iných produktov.",
    "AIComment": "Coca-Cola (KO) vykazuje stabilný rast a pozitívne technické indikátory, ako sú RSI a MACD nad signálnou líniou, čo naznačuje možný pokračujúci rast. Avšak, negatívny trhový trend a neutrálny sektorový trend môžu obmedziť potenciál rastu v krátkodobom horizonte 2-10 dní.",
    "AIScore": 65,
    "SL": 69.46,
    "TP": 74.47,
    "SL10": 9.7,
    "TP10": 10.4
  },
  {
    "ticker": "CNP",
    "name": "CenterPoint Energy",
    "marketCap": 25912340480,
    "revenueGrowth": 0.071,
    "debtToEquity": 202.111,
    "trailingPE": 25.12025,
    "momentum_2m": 0.05799368020194873,
    "momentum_1w": 0.024522377570526332,
    "FundamentalFilterRating": 83,
    "price": 39.689998626708984,
    "RSI (14)": 45.11,
    "EMA (20)": 39.25,
    "MACD (12,26,9)": -0.0281,
    "MACD_Signal (12,26,9)": -0.0675,
    "percent_change": 0.53,
    "TechFilterRating": 100.0,
    "news_sentiment_percent": 75.0,
    "social_sentiment_percent": null,
    "sector": "Utilities",
    "sector_name": "XLU",
    "market_change_1d": -0.8256436690967983,
    "market_change_5d": -3.3489572743467533,
    "market_change_20d": -1.7523999751486108,
    "market_trend": "down",
    "sector_change_1d": -0.37962968642131223,
    "sector_change_5d": -0.5462020608295148,
    "sector_change_20d": -1.5340463307420338,
    "sector_trend": "neutral",
    "OverallRating": 77.4,
    "AITicker": "CenterPoint Energy, Inc. is a public utility company providing electricity and natural gas to several markets in the United States.",
    "AIComment": "Considering the current market and sector trends, CenterPoint Energy (CNP) presents a cautious short-term trading opportunity. The overall market is trending downwards, which could negatively impact CNP despite its neutral sector trend and positive news sentiment. The technical indicators like RSI and MACD suggest a lack of strong momentum, although the recent price is slightly above the EMA(20), indicating some resilience.",
    "AIScore": 55,
    "SL": 38.5,
    "TP": 41.28,
    "SL10": 9.7,
    "TP10": 10.4
  }
]